+ Blood and lymphatic system disorders | Blood | Current |
+ Cardiac disorders | Card | Current |
+ Congenital, familial and genetic disorders | Cong | Current |
+ Ear and labyrinth disorders | Ear | Current |
+ Endocrine disorders | Endo | Current |
+ Eye disorders | Eye | Current |
+ Gastrointestinal disorders | Gastr | Current |
+ General disorders and administration site conditions | Genrl | Current |
+ Hepatobiliary disorders | Hepat | Current |
+ Immune system disorders | Immun | Current |
+ Infections and infestations | Infec | Current |
+ Injury, poisoning and procedural complications | Inj&P | Current |
+ Investigations | Inv | Current |
+ Metabolism and nutrition disorders | Metab | Current |
+ Musculoskeletal and connective tissue disorders | Musc | Current |
- Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Neopl | Current |
+ Breast neoplasms benign (incl nipple) | | Current |
+ Breast neoplasms malignant and unspecified (incl nipple) | | Current |
+ Cancer-related morbidities | | Non-Current |
+ Cutaneous neoplasms benign | | Current |
+ Endocrine neoplasms benign | | Current |
+ Endocrine neoplasms malignant and unspecified | | Current |
+ Gastrointestinal neoplasms benign | | Current |
- Gastrointestinal neoplasms malignant and unspecified | | Current |
+ Anal canal neoplasms malignant | | Current |
- Colonic neoplasms malignant | | Current |
+ Colorectal and anal neoplasms malignancy unspecified | | Current |
+ Colorectal neoplasms malignant | | Current |
- Gastric neoplasms malignant | | Current |
+ Adenocarcinoma gastric | | Current |
+ Gastric cancer | | Current |
+ Gastric cancer recurrent | | Current |
+ Gastric cancer stage 0 | | Current |
+ Gastric cancer stage I | | Current |
+ Gastric cancer stage II | | Current |
+ Gastric cancer stage III | | Current |
+ Gastric cancer stage IV | | Current |
+ Gastric sarcoma | | Current |
+ Gastrooesophageal cancer | | Current |
+ HER-2 positive gastric cancer | | Current |
+ Linitis plastica | | Current |
+ Metastatic gastric cancer | | Current |
+ Gastrointestinal neoplasms malignancy unspecified NEC | | Current |
+ Gastrointestinal neoplasms malignant NEC | | Current |
+ Lip and oral cavity neoplasms malignancy unspecified | | Current |
+ Lip and oral cavity neoplasms malignant | | Current |
+ Oesophageal neoplasms malignancy unspecified | | Current |
+ Oesophageal neoplasms malignant | | Current |
+ Pancreatic neoplasms malignant (excl islet cell and carcinoid) | | Current |
+ Rectal neoplasms malignant | | Current |
+ Salivary gland neoplasms malignant | | Current |
+ Salivary gland neoplasms unspecified malignancy | | Current |
+ Small intestinal neoplasms malignant | | Current |
+ Haematopoietic neoplasms (excl leukaemias and lymphomas) | | Current |
+ Hepatic and biliary neoplasms benign | | Current |
+ Hepatobiliary neoplasms malignant and unspecified | | Current |
+ Leukaemias | | Current |
- Lymphomas Hodgkin's disease | | Current |
- Hodgkin's disease lymphocyte depletion type | | Current |
+ Hodgkin's disease lymphocyte depletion stage I site unspecified | | Current |
+ Hodgkin's disease lymphocyte depletion stage I subdiaphragm | | Current |
+ Hodgkin's disease lymphocyte depletion stage I supradiaphragm | | Current |
+ Hodgkin's disease lymphocyte depletion stage II site unspecified | | Current |
+ Hodgkin's disease lymphocyte depletion stage II subdiaphragm | | Current |
+ Hodgkin's disease lymphocyte depletion stage II supradiaphragm | | Current |
+ Hodgkin's disease lymphocyte depletion type recurrent | | Current |
+ Hodgkin's disease lymphocyte depletion type refractory | | Current |
+ Hodgkin's disease lymphocyte depletion type stage III | | Current |
+ Hodgkin's disease lymphocyte depletion type stage IV | | Current |
+ Hodgkin's disease lymphocyte depletion type stage unspecified | | Current |
+ Hodgkin's disease lymphocyte predominance type | | Current |
+ Hodgkin's disease mixed cellularity type | | Current |
+ Hodgkin's disease NEC | | Current |
- Hodgkin's disease nodular sclerosis type | | Current |
+ Hodgkin's disease nodular sclerosis | | Current |
+ Hodgkin's disease nodular sclerosis recurrent | | Current |
+ Hodgkin's disease nodular sclerosis refractory | | Current |
+ Hodgkin's disease nodular sclerosis stage I | | Current |
+ Hodgkin's disease nodular sclerosis stage II | | Current |
+ Hodgkin's disease nodular sclerosis stage III | | Current |
+ Hodgkin's disease nodular sclerosis stage IV | | Current |
+ Lymphomas NEC | | Current |
- Lymphomas non-Hodgkin's B-cell | | Current |
+ B-cell lymphomas NEC | | Current |
+ B-cell small lymphocytic lymphomas | | Current |
+ B-cell unclassifiable lymphomas | | Current |
+ Burkitt's lymphomas | | Current |
- Diffuse large B-cell lymphomas | | Current |
+ Diffuse large B-cell lymphoma | | Current |
+ Diffuse large B-cell lymphoma recurrent | | Current |
+ Diffuse large B-cell lymphoma refractory | | Current |
+ Diffuse large B-cell lymphoma stage I | | Current |
- Diffuse large B-cell lymphoma stage II | | Current |
+ B-immunoblastic lymphoma (Kiel Classification) stage II | | Current |
+ B-large cell anaplastic Lymphoma (Kiel Classification) stage II | | Current |
+ Centroblastic lymphoma stage II | | Current |
+ Diffuse large cell cleaved lymphoma (Working Formulation) stage II | | Current |
+ Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) stage II | | Current |
+ Diffuse mixed small and large cell lymphoma (Diffuse large B-cell lymphoma) stage II | | Current |
+ Large cell immunoblastic lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) stage II | | Current |
+ Reticulosarcoma involving lymph nodes of axilla and upper limb | | Current |
+ Reticulosarcoma involving lymph nodes of head, face, and neck | | Current |
+ Reticulosarcoma involving lymph nodes of inguinal region and lower limb | | Current |
+ Reticulosarcoma stage II | | Current |
+ Diffuse large B-cell lymphoma stage III | | Current |
+ Diffuse large B-cell lymphoma stage IV | | Current |
+ Richter's syndrome | | Current |
+ Extranodal marginal zone B-cell lymphomas (low grade B-cell) | | Current |
+ Follicle centre lymphomas diffuse predominantly small cell | | Current |
+ Follicle centre lymphomas, follicular grade I, II, III | | Current |
+ High grade B-cell lymphomas Burkitt-like lymphoma | | Current |
+ Lymphoplasmacytoid lymphomas/immunocytomas | | Current |
+ Mantle cell lymphomas | | Current |
+ Marginal zone lymphomas NEC | | Current |
+ Nodal marginal zone B-cell lymphomas | | Current |
+ Precursor B-lymphoblastic lymphomas | | Current |
- Primary mediastinal large B-cell lymphomas | | Current |
+ Primary mediastinal large B-cell lymphoma | | Current |
+ Primary mediastinal large B-cell lymphoma recurrent | | Current |
+ Primary mediastinal large B-cell lymphoma refractory | | Current |
+ Primary mediastinal large B-cell lymphoma stage I | | Current |
+ Primary mediastinal large B-cell lymphoma stage II | | Current |
+ Primary mediastinal large B-cell lymphoma stage III | | Current |
+ Primary mediastinal large B-cell lymphoma stage IV | | Current |
+ Splenic marginal zone lymphomas | | Current |
+ Waldenstrom's macroglobulinaemias | | Current |
+ Lymphomas non-Hodgkin's T-cell | | Current |
+ Lymphomas non-Hodgkin's unspecified histology | | Current |
+ Mesotheliomas | | Current |
+ Metastases | | Current |
+ Miscellaneous and site unspecified neoplasms benign | | Current |
+ Miscellaneous and site unspecified neoplasms malignant and unspecified | | Current |
+ Neoplasm related morbidities | | Current |
+ Nervous system neoplasms benign | | Current |
+ Nervous system neoplasms malignant and unspecified NEC | | Current |
+ Ocular neoplasms | | Current |
+ Plasma cell neoplasms | | Current |
+ Renal and urinary tract neoplasms benign | | Current |
+ Renal and urinary tract neoplasms malignant and unspecified | | Current |
+ Reproductive and genitourinary neoplasms gender unspecified NEC | | Current |
+ Reproductive neoplasms female benign | | Current |
+ Reproductive neoplasms female malignant and unspecified | | Current |
+ Reproductive neoplasms male benign | | Current |
+ Reproductive neoplasms male malignant and unspecified | | Current |
+ Respiratory and mediastinal neoplasms benign (excl mesotheliomas) | | Current |
+ Respiratory and mediastinal neoplasms malignant and unspecified | | Current |
+ Skeletal neoplasms benign | | Current |
+ Skeletal neoplasms malignant and unspecified | | Current |
+ Skin neoplasms malignant and unspecified | | Current |
+ Soft tissue neoplasms benign | | Current |
+ Soft tissue neoplasms malignant and unspecified | | Current |
+ Soft tissue neoplasms malignant and unspecified (excl sarcomas) | | Current |
+ Soft tissue sarcomas | | Current |
+ Nervous system disorders | Nerv | Current |
+ Pregnancy, puerperium and perinatal conditions | Preg | Current |
+ Product issues | Prod | Current |
+ Psychiatric disorders | Psych | Current |
+ Renal and urinary disorders | Renal | Current |
+ Reproductive system and breast disorders | Repro | Current |
+ Respiratory, thoracic and mediastinal disorders | Resp | Current |
+ Skin and subcutaneous tissue disorders | Skin | Current |
+ Social circumstances | SocCi | Current |
+ Surgical and medical procedures | Surg | Current |
+ Vascular disorders | Vasc | Current |
Standard View
|